Top Markets
Coin of the day
NeuroMetrix, Inc. NeuroMetrix, Inc.

NeuroMetrix, Inc.

NURO
Peringkat dalam Saham #33738
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing,... NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.
Harga Saham
$4.58
Terakhir disinkronkan: 2025-05-09
Kapitalisasi Pasar
$6.98M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan NeuroMetrix, Inc. (NURO)

Kategori

Rasio P/E untuk NeuroMetrix, Inc. (NURO)
Rasio P/E per August 2026 TTM: -1.16
Menurut laporan keuangan dan harga saham terbaru dari NeuroMetrix, Inc., rasio P/E saat ini (TTM) adalah -1.16. Pada akhir 2023, perusahaan memiliki rasio P/E sebesar -0.57.
Riwayat rasio P/E untuk NeuroMetrix, Inc. dari 2001 hingga 2026
Rasio P/E di akhir setiap tahun
Tahun Rasio P/E Mengubah
2026 (TTM) -1.16 15.66%
2024 -1.00 74.47%
2023 -0.57 -76.40%
2022 -2.43 -94.79%
2021 -46.72 -2.30%
2020 -47.82 326.96%
2019 -11.20 -100.58%
2018 1.95K -106,362.74%
2017 -1.83 -31.10%
2016 -2.66 -61.91%
2015 -6.98 -57.39%
2014 -16.38 -5.44%
2013 -17.32 292.25%
2012 -4.42 14.37%
2011 -3.86 -47.92%
2010 -7.41 -73.35%
2009 -27.81 706.91%
2008 -3.45 -96.89%
2007 -110.91 -131.75%
2006 349.34 -87.63%
2005 2.82K -1,170.22%
2004 -263.90 29.91%
2003 -203.14 30.73%
2002 -155.39 81.86%
2001 -85.44 0.00%
Rasio P/E untuk perusahaan serupa atau pesaing
Perusahaan Rasio P/E Perbedaan Rasio P/E Negara
35.77 -3,193.11%
US
34.86 -3,114.21%
US
21.39 -1,949.20%
IE
20.90 -1,906.95%
US
52.64 -4,651.59%
US
Bagaimana cara membaca P/E ratio?

Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.

Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.

Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.